Clinical trial
Induced Pluripotent Stem Cells for the Development of Novel Drug Therapies for Hepatic and Neurological Niemann Pick Disease
NCT03883750 is registered in ClinicalTrials.gov with CENTOGENE GmbH Rostock as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Induced Pluripotent Stem Cells for the Development of Novel Drug Therapies for Hepatic and Neurological Niemann Pick Disease
- Lead sponsor
- CENTOGENE GmbH Rostock
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 19, 2018
- Completion date
- December 1, 2019
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.